Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation

OBJECTIVE: To define the pharmacokinetic (PK) parameters of 17-hydroxyprogesterone caproate (17-OHPC) in multifetal gestation. STUDY DESIGN: Blood was obtained at 24–28 weeks and at 32–35 weeks in 97 women with twin and 26 women with triplet gestation receiving 17-OHPC. Six of the women with twins h...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Caritis, Steve N., Sharma, Shringi, Venkataramanan, Raman, Rouse, Dwight J., Peaceman, Alan M., Sciscione, Anthony, Spong, Catherine Y., Varner, Michael W., Malone, Fergal D., Iams, Jay D., Mercer, Brian M., Thorp, John M, Sorokin, Yoram, Carpenter, Marshall, Lo, Julie, Ramin, Susan, Harper, Margaret
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165062/
https://ncbi.nlm.nih.gov/pubmed/21620357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2011.03.028
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires